Assessment Of The 12-lead ECG As A Screening Test For CVD In Healthy Young People
Assessment of the 12-Lead ECG as a Screening Test for the Detection of Cardiovascular Disease in Healthy General Populations of Young People (12-25 years of age)
Mandatory and universal cardiovascular mass screening with 12-lead ECGs in large general populations of young healthy people 12-25 years of age to identify genetic/congenital and other cardiovascular abnormalities is not recommended for athletes and non-athletes alike.
Consideration for large-scale, general population and universal cardiovascular screening in the age group 12 to 25 years with history–taking and physical examination alone is not recommended.
Use by examiners of the AHA 14-point elements and those from other societies as a part of comprehensive history–taking and physical examination to detect or raise suspicion of genetic/congenital and other cardiovascular abnormalities is recommended for cardiovascular screening in young people aged 12 to 25 years.